Antiplatelet therapy before or after 16 weeks’ gestation for preventing preeclampsia: an individual participant data meta-analysis

American Journal of Obstetrics and Gynecology

Volumn 216, Issue 2, 2017, Pages 121-128.e2

  Meher, Shireen ^a,b   Duley, Lelia ^c   Hunter, Kylie ^d   Askie, Lisa ^d  

^a CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

antiplatelets; aspirin; gestation; preeclampsia; prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

DRUG EFFECT; FETUS DEATH; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; LOW DRUG DOSE; META ANALYSIS; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SMALL FOR DATE INFANT; SYSTEMATIC REVIEW; FEMALE; FIRST TRIMESTER PREGNANCY; NEWBORN; PERINATAL DEATH; PRE-ECLAMPSIA; PREGNANCY; PREMATURE BIRTH; SECOND TRIMESTER PREGNANCY; TIME FACTOR;

ASPIRIN; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PERINATAL DEATH; PLATELET AGGREGATION INHIBITORS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREMATURE BIRTH; TIME FACTORS;

EID: 85010874917     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2016.10.016     Document Type: Review

References (60)

1. 1 Duley, L., Meher, S., Hunter, K., Askie, L., Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev(2), 2007 Apr 18, CD004659.
2. 2 CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 343 (1994), 619–629.
3. 3 Golding, J., A randomized trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group. BJOG 105 (1998), 293–299.
4. 4 Rotchell, Y.E., Cruickshank, J.K., Gay, M.P., et al. Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomized trial for the prevention of pre-eclampsia and its complications. BJOG 105 (1998), 286–292.
5. 5 Duley, L., Henderson-Smart, D., Knight, M., King, J., Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. BMJ 322 (2001), 329–333.
6. 6 Imperiale, T.F., Petrulis, A.S., A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 266 (1991), 260–264.
7. 7 Meher, S., Alfirevic, Z., Aspirin for pre-eclampsia: beware of subgroup meta-analysis. Ultrasound Obstet Gynecol 41 (2013), 479–485.
8. 8 Duley, L., Henderson-Smart, D.J., Meher, S., King, J.F., Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev, 2007, CD004659.
9. 9 Askie, L.M., Duley, L., Henderson-Smart, D.J., Stewart, L.A., Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 369 (2007), 1791–1798.
10. 10 Parazzini, F., Bortolus, R., Chatenoud, L., Restelli, S., Benedetto, C., Follow-up of children in the Italian Study of Aspirin in Pregnancy. Lancet, 343, 1994, 1235.
11. 11 CLASP Collaborative Group. Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. BJOG 102 (1994), 861–868.
12. 12 National Institute for Health and Care Excellence. Hypertension in Prenancy. Management of Hypertensive Disorders in Pregnancy. NICE clinical guideline no. 107. Issued 2010, updated January 2011. Available at: http://www.nice.org.uk/nicemedia/live/13098/50418/50418.pdf. Accessed May 8, 2015.
13. 13 Magee, L., Pels, A., Helewa, M.E., Rey, E., von Dadelszen, P., Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. SOGC Practice Bulletin no. 307, May 2014. Executive Summary. Obstet Gynaecol Can 36 (2014), 416–438.
14. 14 Lowe SA, Bowyer L, Lust K, et al. SOMANZ guideline for the management of hypertensive disorders of pregnancy 2014. Available at: https://somanz.org/documents/HTPregnancyGuidelineJuly2014. Accessed May 8, 2014.
15. 15 Report of the ACOG Task Force on Hypertension in Pregnancy. Obstet Gynecol 122 (2013), 1122–1131.
16. 16 World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. 2011, World Health Organization Available at: http://whqlibdoc.who.int/publications/2011/9789241548335_eng.pdf Accessed May 8, 2015.
17. 17 Roberge, S., Nicolaides, K., Demers, S., Villa, P., Bujold, E., Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol 41 (2013), 491–499.
18. 18 Bujold, E., Roberge, S., Lacasse, Y., et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 116 (2010), 402–414.
19. 19 The Perinatal Antiplatelet Review of International Studies (PARIS) Collaboration Steering Group on behalf of the PARIS Collaboration. Antiplatelet agents for prevention of pre-eclampsia and its consequences: a systematic review and individual patient data meta-analysis. BMC Pregnancy Childbirth, 5, 2005, 7.
20. 20 Michael, C.A., Walters, B.N.J., Low-dose aspirin in the prevention of pre-eclampsia: current evaluation. Teoh, E.S., Ratnam, S.S., Macnaughton, M.C., (eds.) Maternal physiology and pathology. The current status of gynaecology and obstetrics series, 1992, Parthenon Publishing Group Limited, Carnforth (United Kingdom), 183–189.
21. 21 Kincaid Smith, P., North, R.A., Fairley, K.F., Kloss, M., Ihle, B.U., Prevention of pre-eclampsia in high risk women with renal disease: a prospective randomized trial of heparin and dipyridamole. Nephrology 1 (1995), 297–300.
22. 22 ECPPA (Estudo Colorativo para Prevencao da Pre-eclampsia com Aspirina) Collaborative Group. ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnancies. BJOG 103 (1996), 39–47.
23. 23 Uzan, S., Beaufils, M., Breart, G., Bazin, B., Capitant, C., Paris, J., Prevention of fetal growth retardation with low-dose aspirin: findings of the EPREDA trial. Lancet 337 (1991), 1427–1431.
24. 24 Subtil, D., Goeusse, P., Puech, F., et al. Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (ERASME) (Part 1). BJOG 110 (2003), 475–484.
25. 25 Vainio, M., Kujansuu, E., Iso-Mustajarvi, M., Maenpaa, J., Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 109 (2002), 161–167.
26. 26 Uzan, S., Beaufils, M., Bazin, B., Danays, T., Idiopathic recurrent fetal growth retardation and aspirin-dipyridamole therapy. Am J Obstet Gynecol 160 (1989), 763–764.
27. 27 Railton A, Davey DA. Aspirin and dipyridamole in the prevention of pre-eclampsia: effect on plasma 6 keto PGF1alpha and TxB2 and clinical outcome of pregnancy. Presented at the 1st European Congress on Prostaglandins in Reproduction, July 6-9, 1988, Vienna, Austria, page 48.
28. 28 Hermida, R.C., Ayala, D.E., Iglesias, M., Administration time-dependant influence of aspirin on blood pressure in pregnant women. Hypertension 41 (2003), 651–656.
29. 29 Yu, C.K.H., Papageorghiou, A.T., Parra, M., Palma Dias, R., Nicolaides, K.H., Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine Doppler at 23 weeks gestation. Ultrasound Obstet Gynecol 22 (2003), 233–239.
30. 30 Sibai, B.M., Caritis, S.N., Thom, E., et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 329 (1993), 1213–1218.
31. 31 August P, Helseth G, Edersheim TG, Hutson JM, Druzin M. Sustained release, low-dose aspirin ameliorates but does not prevent preeclampsia (PE) in a high risk population. In: Presented at the 9th International Congress, International Society for the Study of Hypertension in Pregnancy, March 15-18, 1994, Sydney, Australia, page 72.
32. 32 Caritis, S., Sibai, B., Hauth, J., et al. Low-dose aspirin to prevent preeclampsia in women at high risk. N Engl J Med 338 (1998), 701–705.
33. 33 Byaruhanga, R.N., Chipato, T., Rusakaniko, S., A randomized controlled trial of low-dose aspirin in women at risk from pre-eclampsia. Int J Gynecol Obstet 60 (1998), 129–135.
34. 34 Morris, J.M., Fay, R.A., Ellwood, D.A., Cook, C., Devonald, K.J., A randomized controlled trial of aspirin in patients with abnormal uterine artery blood flow. Obstet Gynecol 87 (1996), 74–78.
35. 35 Wang, Z., Li, W., A prospective randomized placebo-controlled trial of low dose aspirin for prevention of intra uterine growth retardation. Chin Med J 109 (1996), 238–242.
36. 36 Rogers, M.S., Fung, H.Y.M., Hung, C.Y., Calcium and low-dose aspirin prophylaxis in women at high risk of pregnancy-induced hypertension. Hypertens Pregnancy 18 (1999), 165–172.
37. 37 Zimmermann, P., Eirio, V., Koskinen, J., et al. Effect of low dose aspirin treatment on vascular resistance in the uterine, uteroplacental, renal and umbilical arteries—a prospective longitudinal study on a high risk population with persistent notch in the uterine arteries. Eur J Ultrasound 5 (1997), 17–30.
38. 38 Schiff, E., Peleg, E., Goldenberg, M., et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 321 (1989), 351–356.
39. 39 Hauth, J.C., Goldenberg, R.L., Parker, C.R. Jr., et al. Low-dose aspirin therapy to prevent preeclampsia. Am J Obstet Gynecol 168 (1993), 1083–1093.
40. 40 Kincaid-Smith P. Trial to evaluate the role of aspirin (60 mg) in the prevention of idiopathic intrauterine growth retardation and pregnancy induced hypertension in primigravid women with abnormal uterine artery waveforms on Doppler examination at 22–24 weeks gestation. Personal communication, Oct. 30, 1991.
41. 41 Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Italian Study of Aspirin in Pregnancy. Lancet 341 (1993), 396–400.
42. 42 Gallery, E.D.M., Ross, M.R., Hawkins, M., Leslie, G.I., Gyory, A.Z., Low-dose aspirin in high-risk pregnancy. Hypertens Pregnancy 16 (1997), 229–238.
43. 43 Chiaffarino, F., Parazzini, F., Paladini, D., et al. A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 112 (2004), 142–144.
44. 44 Xu, T.T., Zhou, F., Deng, C.Y., Huang, G.Q., Li, J.K., Wang, X.D., Low-dose aspirin for preventing preeclampsia and its complications: a meta-analysis. J Clin Hypertens 17 (2015), 567–573.
45. 45 Dickersin, K., The existence of publication bias and risk factors for its occurrence. JAMA 263 (1990), 1385–1389.
46. 46 Haapsamo, M., Martikainen, H., Rasanen, J., Low-dose aspirin reduces uteroplacental vascular impedance in early and mid gestation in IVF and ICSI patients: a randomized, placebo controlled double-blind study. Ultrasound Obstet Gynecol 32 (2008), 687–693.
47. 47 Tarim, E., Bal, N., Kilicdag, E., Kayaselcuk, F., Bag, T., Kuscu, E., Effects of aspirin on placenta and perinatal outcomes in patients with poor obstetric history. Arch Gynecol Obstet 274 (2006), 209–214.
48. 48 Han, C.S., Mulla, M.J., Brosens, J.J., et al. Aspirin and heparin effect on basal and antiphospholipid antibody modulation of trophoblast function. Obstet Gynecol 118 (2011), 1021–1028.
49. 49 Grab, D., Paulus, W.E., Erdmann, M., et al. Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial. Ultrasound Obstet Gynecol 15 (2000), 19–27.
50. 50 Pijnenborg, R., Bland, J.M., Robertson, W.B., Brosens, I., Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 4 (1983), 397–413.
51. 51 Lyall, F., Priming and remodelling of human placental bed spiral arteries during pregnancy-a review. Placenta 26:Suppl A (2005), S31–S36.
52. 52 Bakhti, A., Vaiman, D., Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation. Hypertens Res 34 (2011), 1116–1120.
53. 53 Ebrashy, A., Ibrahim, M., Marzook, A., Yousef, D., Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial. Croat Med J 46 (2005), 826–831.
54. 54 Mesdaghinia, E., Talari, H., Abedzadeh-Kalahroudi, M., Effect of aspirin for prevention of preeclampsia in women with abnormal ultrasonic findings in uterine artery. Feyz J Kashan Univ Med Sci 15 (2011), 98–104.
55. 55 Villa, P.M., Kajantie, E., Raikkonen, K., et al. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG 120 (2013), 64–74.
56. 56 Lambers, M.J., Groeneveld, E., Hoozemans, D.A., et al. Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy. Hum Reprod 24 (2009), 2447–2450.
57. 57 Vaseie, M., The effect of low-dose acetylsalicylic acid (ASA) on control of hypertensive in pregnancy. Hypertens Pregnancy, 25(Suppl 1), 2006, 148.
58. 58 Jamal, A., Milani, F., Al-Yasin, A., Evaluation of the effect of metformin and aspirin on utero placental circulation of pregnant women with PCOS. Iran J Reprod Med 10 (2012), 265–270.
59. 59 Kozer, E., Nifkar, S., Costei, A., Boskovic, R., Nulman, I., Koren, G., Aspirin consumption during the first trimester of pregnancy and congenital abnormalities: a meta-analysis. Am J Obstet Gynaecol 187 (2002), 1623–1630.
60. 60 Akolekar, R., Syngelaki, A., Poon, L., Wright, D., Nicolaides, K.H., Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 33 (2013), 8–15.